drugset / Trial / NCT00378287

A Study to Monitor Intragastric pH in Patients Taking Rabeprazole vs. Patients Taking Pantoprazole

NCT00378287

Phase 1 Completed 37 enrolled Janssen-Ortho Inc., Canada
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of the study is to demonstrate in patients that oral rabeprazole produces equivalent acid suppression to intravenous pantoprazole on Day 1 of drug administration.

Timeline

Start
2005-10
Primary completion
Completion
2005-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Rabeprazole Small molecule 20 mg Oral